The National Diabetes Statistics Report, released approximately every 2 years, provides information on diabetes prevalence and incidence, prediabetes, risk factors for complications, acute and long-term complications, mortality, and costs in the United States.
Type 2 diabetes can alter the oral microbiome and lead to inflammation.
Web-based weight loss intervention shows promise addressing obesity in patients with type 2 diabetes.
An asthma drug may potentially be useful in treating type 2 diabetes, according to a recently-published study.
The Alexa Diabetes Challenge harnesses voice-activated technology to improve diabetes outcomes.
Top news of the day from across the health care landscape.
The number of patients who have from diabetes is expected to almost double from 285 million to 438 million people by 2030 due to obesity trends.
SmartMat offers early protection against nontraumatic plantar foot ulcers foot ulcers before presentation.
Amlexanox may alter genes that improve blood glucose control in patients with type 2 diabetes.
Top news of the day from across the health care landscape.
Patients with obstructive sleep apnea and type 2 diabetes have an increased risk of retinopathy.
Children diagnosed with diabetic ketoacidosis and type 1 diabetes may have higher HbA1C levels.
Pharmacists’ roles are expanding from traditional retail settings, allowing them to be more involved in patient care than ever before.
Top news of the day from across the health care landscape.
Top news of the day from across the health care landscape.
Eradicating hepatitis C virus with antiviral drugs found to improve comorbid conditions.
Diabetes' propensity to cause metabolic derangement is directly responsible for a looming epidemic of diabetic kidney disease (DKD). And left unchecked, DKD can progress to end-stage kidney disease (ESKD).
How can we reduce the burden of type 1 diabetes? Automated insulin delivery systems could be the answer.
A diabetes wearable device can measure cortisol, glucose, and interleukin-6 in sweat to track disease progession.
Dutasteride (Avodart) increases blood sugar, A1C, and blood lipids.
Liraglutide is an injectable prescription drug that may improve glucose in adults with type 2 diabetes.
Prebiotics seen to reduce weight gain among pediatric patients who were overweight or obese.
Patients with diabetes could benefit greatly from technological advances.
Approximately 72% of Medicare beneficiaries have at least 2 chronic medical conditions (most often diabetes, heart disease, and asthma/COPD), and roughly 40% have 4 or more.
Top articles of the week from The American Journal of Pharmacy Benefits.
